Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. (Q52621157)
Jump to navigation
Jump to search
scientific article published on 19 March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. |
scientific article published on 19 March 2018 |
Statements
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial (English)
Philippe Rosset
Florian Gebhard
Philippe Hernigou
Helène Rouard
Luc Sensebé
Rosa M Gonzalo-Daganzo
Rosaria Giordano
Norma Padilla-Eguiluz
Eduardo García-Rey
José Cordero-Ampuero
Juan Carlos Rubio-Suárez
Julien Stanovici
Christian Ehrnthaller
Davide Maria Donati
Gabriela Ciapetti
Sandrine Fleury
Manuel-Nicolás Fernandez
José-Rafael Cabrera
Cristina Avendaño-Solá
Tiziana Montemurro
Carmen Panaitescu
Elena Veronesi
Ramin Lotfi
Hubert Schrezenmeier
Markus Huber-Lang